|Articles|June 1, 2017
- Pharmaceutical Executive-06-01-2017
- Volume 37
- Issue 6
Pharmaceutical Executive, June 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Pharm Exec's Top 50 Companies 2017almost 9 years ago
Navigating Through Disruption: A Pharma 50 Viewalmost 9 years ago
Tips for Success from a Big Pharma Leaderalmost 9 years ago
The Quest for Meaningful Pharma-Patient Dialoguealmost 9 years ago
Executive Roundtable: Where is Your Physician?almost 9 years ago
Talent That Takes You into the Futureabout 9 years ago
Europe: A Long Summer of Drug Pricing Tensionabout 9 years ago
Gottlieb Takes Reins at FDA, Big Issues Loomabout 9 years ago
Country Report: TaiwanAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
5